PharmaMar Initiates the Phase III Study CORAIL for the Anticancer Agent PM1183 Platinum-resistant Ovarian Cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Tuesday, June 30, 2015

PharmaMar Initiates the Phase III Study CORAIL for the Anticancer Agent PM1183 Platinum-resistant Ovarian Cancer



Press release

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.